1. 2000 NMT was founded by Prof. Jimmy Yun & Prof. Chen Jianfeng
Listed in LUX Research as one of the top 7 private Asian nanotech company
Started to use HGCP Technology for Pharmaceutical applications
Established Pharmaceutical Division
Opened its US$2.5-million new facility in Singapore
Successfully developed pulmonary inhalable drug particles for anti-asthma, anti-diabetes and anti-migraine
Licensed out HGCP Technology for manufacturing formulated cholesterol lowering drug to Beijing Winsunny
HGCP Technology received Special Award at Nanotech Japan 2013
Signed clinical trial material supply contract with Christus Stehlin on CZ-48 anti-cancer drug
Partnered with Micro-Sphere Switzerland to use its GMP manufacturing facility. Produced first batch of CZ-48 capsules
Spin-off Pharmaceutical Division to establish NMT Pharmaceuticals Pte Ltd
Signed LOI with CAO Pharmaceuticals on development & marketing right for CZ-48.
2004
2006
2008
2014
2013
2010
2015
2016
Signed Licensing Agreement with CAO Pharmaceuticals on exclusive worldwide development & marketing right for CZ-48
Started CZ-48 Clinical Trial Phase I in USA
Acquired 100% by NMT Holding
Invested in CAO Pharmaceuticals